Tops & Flops
Security | Change (%) | 1w ▼ | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Immune Pharmaceuticals Inc | 9.820% | 180.000% | 761.538% | 2700.000% | 2504.651% | -53.909% | -97.879% |
Novocure Ltd | -4.640% | 49.281% | 40.738% | 166.282% | 19.856% | - | - |
Trevena Inc. | -18.890% | 26.078% | 6.742% | 201.014% | 10.305% | - | - |
Affimed N.V. | -1.140% | 18.896% | 28.597% | 298.228% | 61.765% | - | - |
Flexion Therapeutics Inc. | 0.640% | 15.714% | -18.182% | 1.250% | -9.497% | - | - |
DBV Technologies S.A. ADR | -2.910% | 14.955% | 8.193% | 25.610% | 187.709% | -73.316% | -83.773% |
Paratek Pharma | -0.810% | 14.649% | 1.469% | 63.408% | 34.539% | -34.904% | -53.980% |
Novavax Inc. | 12.640% | 14.065% | -7.805% | 948.614% | 74.545% | 481.655% | 75.708% |
Rigel Pharmaceutical Inc. | -3.490% | 13.006% | -10.398% | 110.267% | 9.514% | - | - |
Supernus Pharmaceuticals | 1.500% | 12.605% | 17.544% | 55.814% | 30.097% | - | - |
Boiron S.A. | -1.270% | 11.268% | 7.046% | 21.538% | -0.878% | -43.571% | -45.182% |
Celldex Therapeutics | 0.760% | 10.767% | -5.891% | 1116.718% | 40.357% | -28.415% | -68.419% |
Ardelyx Inc. | 0.690% | 9.848% | 24.399% | 47.358% | 25.563% | - | - |
Prothena Corp. plc | 6.000% | 9.645% | 3.846% | 101.869% | 113.861% | - | - |
Inotiv Inc. | -7.210% | 8.964% | 37.103% | 370.859% | 121.976% | 1415.935% | 1894.225% |
Redhill Biopharma Ltd ADR | -3.580% | 8.865% | -9.037% | -9.706% | -17.584% | - | - |
Halozyme Therapeutics Inc. | -0.670% | 8.834% | 2.991% | 128.166% | 11.060% | - | - |
Biocryst Pharmaceuticals | -2.150% | 8.572% | -16.307% | 282.170% | 67.385% | 152.640% | 248.565% |
Dynavax Technologies Corp | 1.450% | 8.489% | 4.443% | 222.001% | 135.750% | -43.535% | -52.217% |
MEI Pharma Inc | -1.020% | 8.405% | -5.094% | - | 39.722% | - | - |
Medpace Holdings Inc | -2.580% | 8.392% | 13.139% | 103.947% | 37.168% | - | - |
Xenon Pharmaceuticals Inc. | 3.750% | 8.108% | -6.433% | 31.148% | 37.931% | 286.473% | 153.044% |
Puma Biotechnology Inc. | 3.080% | 7.905% | -11.776% | 8.662% | 3.049% | - | - |
Merrimack Pharmaceuticals Inc. | 3.600% | 7.767% | -6.723% | 80.195% | 3.738% | -21.499% | -92.204% |
Virbac S.A. | 5.420% | 7.623% | 6.195% | 47.239% | 1.911% | 102.020% | 49.392% |